As behind the scenes negotiations to purchase Allergan, Inc. (NYSE:AGN) are ongoing – and ValueWalk sources who had been providing a steady stream of behind the scenes information take a more circumspect tone – comes a Bank of Montreal analysis that supports Allergan’s claims that they have won the important hearts and minds of doctors.
Valeant and Allergan fighting to win support of ophthalmologists
Doctors and more specifically ophthalmologists are a key influencer in the decision making...